Nizar M Tannir

Nizar M Tannir

UNVERIFIED PROFILE

Are you Nizar M Tannir?   Register this Author

Register author
Nizar M Tannir

Nizar M Tannir

Publications by authors named "Nizar M Tannir"

Are you Nizar M Tannir?   Register this Author

100Publications

2501Reads

42Profile Views

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Cancer Cell 2019 Feb;35(2):204-220.e9

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.01.006DOI Listing
February 2019

Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma.

Cancer Treat Rev 2018 Nov 20;70:127-137. Epub 2018 Jul 20.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.07.009DOI Listing
November 2018

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma.

J Clin Oncol 2018 Jun 11;36(16):1588-1593. Epub 2018 Apr 11.

Eric Jonasch, Rebecca S. Slack, Summer Stovall, Donna Juarez, Troy R. Gilchrist, Lisa Pruitt, and Nizar M. Tannir, The University of Texas MD Anderson Cancer Center; Elshad Hasanov, The University of Texas Health Science Center, Houston, TX; Daniel M. Geynisman and Elizabeth R. Plimack, Fox Chase Cancer Center, Philadelphia, PA; Matthew I. Milowsky, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; W. Kimryn Rathmell, Vanderbilt Ingram Cancer Center, Nashville, TN; and Moshe C. Ornstein and Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.77.1485
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.77.1485DOI Listing
June 2018

A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.

Clin Cancer Res 2018 May 12;24(9):2044-2049. Epub 2018 Feb 12.

Center for Precision Environmental Health, Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-3296DOI Listing
May 2018

Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review.

Oncologist 2018 May 27;23(5):540-555. Epub 2018 Feb 27.

Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947457PMC
May 2018

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

N Engl J Med 2018 Apr 21;378(14):1277-1290. Epub 2018 Mar 21.

From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer Institute, Buffalo (S.G.) - both in New York; University of Texas M.D. Anderson Cancer Center, Houston (N.M.T., P. Sharma); Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center (D.F.M.), and Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School (T.K.C.), Boston; Centro Internacional de Estudios Clínicos (O.A.F.) and Fundación Arturo López Pérez (P. Salman), Santiago, Chile; Palacký University and University Hospital Olomouc, Olomouc, Czech Republic (B.M.); Fox Chase Cancer Center, Philadelphia (E.R.P.); Hôpitaux Universitaires de Strasbourg, Strasbourg (P.B.), Bordeaux University Hospital, Hôpital Saint-André, Bordeaux (A.R.), and Institut Gustave Roussy, Villejuif (B.E.) - all in France; Istituto di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia (C.P.), and Ospedale San Donato, Azienda Unità Sanitaria Locale Toscana Sud-Est, Istituto Toscano Tumori, Arezzo (S.B.) - both in Italy; Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust (T.P.), and Cancer Research UK (R.H.), London; Aarhus University Hospital, Aarhus, Denmark (F.D.); Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv - both in Israel (V.N.); British Columbia Cancer Agency, Vancouver, Canada (C.K.K.); Westmead Hospital and Macquarie University, Sydney (H.G.); Jena University Hospital, Jena, Germany (M.-O.G.); Centro de Pesquisa em Oncologia, Hospital São Lucas, Porto Alegre, Brazil (C.H.B.); Niigata University, Niigata, Japan (Y.T.); Hospital Universitario 12 de Octubre, Madrid (D.C.); Cleveland Clinic Taussig Cancer Institute, Cleveland (B.I.R.); Bristol-Myers Squibb, Princeton, NJ (A.C.C., S.M., M.B.M., M.W.-R., J.D.); and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (H.J.H.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1712126
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1712126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972549PMC
April 2018

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.

J Clin Oncol 2018 Mar 29;36(8):757-764. Epub 2018 Jan 29.

David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL; Bernard Escudier, Institut Gustave Roussy, Villejuif; Florence Marteau, Ipsen Pharma, Boulogne-Billancourt; Paul Williams, Mapi Group, Lyon, France; Nizar M. Tannir, University of Texas MD Anderson Cancer Center Hospital, Houston; Hans J. Hammers, University of Texas Southwestern Medical Center; Thomas E. Hutson, Texas Oncology-Baylor Sammons Cancer Center, Dallas, TX; Thomas Powles, Queen Mary University of London, London, United Kingdom; Frede Donskov, Aarhus University Hospital, Aarhus, Denmark; Katriina Peltola, Helsinki University Hospital Cancer Center, Helsinki, Finland; Manuela Schmidinger, Medical University of Vienna, Vienna, Austria; Daniel Y.C. Heng, University of Calgary, Calgary, Alberta, Canada; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; Jae Lyun Lee, University of Ulsan College of Medicine, Seoul, South Korea; Bruce J. Roth, Washington University in St Louis, St Louis, MO; John Baer, Milan Mangeshkar, and Christian Scheffold, Exelixis, South San Francisco; Sumanta Pal, City of Hope National Medical Center, Duarte, CA; Robert J. Motzer, Memorial Sloan Kettering Cancer Center, New York, NY; and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.2170DOI Listing
March 2018

Papillary Renal Cell Carcinoma: A Family Portrait.

Eur Urol 2018 01 19;73(1):79-80. Epub 2017 Jun 19.

Department of Medical Oncology, Pitié-Salpêtrière Hospital, AP-HP, University Pierre and Marie Curie, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.06.004DOI Listing
January 2018

Recommendations for the Management of Rare Kidney Cancers.

Eur Urol 2017 12 16;72(6):974-983. Epub 2017 Jul 16.

Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.06.040DOI Listing
December 2017

Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy.

AJR Am J Roentgenol 2017 Dec 24;209(6):1278-1284. Epub 2017 Oct 24.

1 Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.17.18018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722466PMC
December 2017

Editorial Comment.

Urology 2017 11 1;109:132. Epub 2017 Sep 1.

The University of Texas, MD Anderson Cancer Center, Austin, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.06.049DOI Listing
November 2017

Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control.

J Bone Joint Surg Am 2017 Nov;99(22):1916-1926

1Department of Radiology, Baylor College of Medicine, Houston, Texas 2Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, Texas 3Departments of Interventional Radiology (K.A., S.Y.H., S.H.S., and A.L.T.), Genitourinary Medical Oncology (N.M.T.), and Orthopaedic Oncology (V.O.L.), University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2106/JBJS.16.01182DOI Listing
November 2017

Glycemic index, glycemic load and carbohydrate intake in association with risk of renal cell carcinoma.

Carcinogenesis 2017 10;38(11):1129-1135

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/carcin/article/38/11/1129/4083558
Publisher Site
http://dx.doi.org/10.1093/carcin/bgx083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862287PMC
October 2017

Examination of moderators of expressive writing in patients with renal cell carcinoma: the role of depression and social support.

Psychooncology 2017 09 3;26(9):1361-1368. Epub 2016 May 3.

Department of Palliative, Rehabilitation & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094904PMC
September 2017

Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma.

Clin Genitourin Cancer 2017 Aug 10. Epub 2017 Aug 10.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.07.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809227PMC
August 2017

Renal Medullary Carcinoma: Establishing Standards in Practice.

J Oncol Pract 2017 07;13(7):414-421

Vanderbilt University Medical Center, Nashville; St Jude Children's Research Hospital, Memphis, TN; University of Texas MD Anderson Cancer Center; Baylor College of Medicine, Houston, TX; American University of Beirut Medical Center, Beirut, Lebanon; Université Paris-Est Créteil, Créteil; Institut Curie; University Pierre and Marie Curie, Paris, France; University of North Carolina at Chapel Hill, Chapel Hill, NC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; Johns Hopkins University, Baltimore, MD; Memorial Sloan Kettering Cancer Center, New York, NY; and University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.020909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508447PMC
July 2017

Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma.

Oncotarget 2017 Jun;8(26):42149-42158

Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522056PMC
June 2017

Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.

Clin Genitourin Cancer 2017 06 18;15(3):363-370. Epub 2017 Jan 18.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.01.010DOI Listing
June 2017

Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities.

Clin Adv Hematol Oncol 2017 May;15(5):409-418

University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
May 2017

Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience.

Am J Clin Oncol 2017 Apr;40(2):189-193

Departments of *Lymphoma †Pathology ∥Urology ¶Sarcoma #Genitourinary Medical Oncology Divisions of ‡Cancer Medicine §Pharmacy, UT MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372498PMC
April 2017

Outcomes of Patients With Metastatic Non-Clear-Cell Renal Cell Carcinoma Treated With Pazopanib.

Clin Genitourin Cancer 2017 04 22;15(2):e205-e208. Epub 2016 Jul 22.

Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.07.016DOI Listing
April 2017

Linking Gene Mutations to Clinical Outcomes and Response to Therapy in Clear-cell Renal Cell Carcinoma: Ready for Prime Time?

Eur Urol 2017 03 2;71(3):415-416. Epub 2016 Nov 2.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.10.034DOI Listing
March 2017

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.

Curr Oncol Rep 2017 Feb;19(2):14

Departments of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Medical School Hannover (MHH), OE6860 Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0566-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331092PMC
February 2017

Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.

J Clin Oncol 2016 10;34(29):3562-3569

Aung Naing, Rivka R. Colen, David S. Hong, and Nizar M. Tannir, MD Anderson Cancer Center, Houston; Kyriakos P. Papadopoulos and Drew R. Rasco, START Center for Cancer Care, San Antonio, TX; Karen A. Autio, Memorial Sloan Kettering Cancer Center, New York, NY; Patrick A. Ott, Dana-Farber Cancer Institute, Boston, MA; Manish R. Patel, Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Deborah J. Wong, University of California Los Angeles, Los Angeles; Melinda Whiteside, John B. Mumm, Ivan H. Chan, Peter Van Vlasselaer, and Martin Oft, ARMO BioSciences, Redwood City, CA; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Shubham Pant, Oklahoma University, Oklahoma City, OK; and Johanna C. Bendell, Todd M. Bauer, and Jeffrey R. Infante, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657013PMC
October 2016

Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials.

Int J Radiat Oncol Biol Phys 2016 08 25;95(5):1405-1413. Epub 2016 Mar 25.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.03.022DOI Listing
August 2016

Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody.

J Immunother Cancer 2016 21;4:36. Epub 2016 Jun 21.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1374, 1155 Pressler Street, Houston, TX 77030-3721 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0139-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915058PMC
June 2016

Proteinuria with first-line therapy of metastatic renal cell cancer.

J Oncol Pharm Pract 2016 Apr 9;22(2):235-41. Epub 2014 Dec 9.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155214563153DOI Listing
April 2016

Personalised cancer care: promises and challenges of targeted therapy.

J R Soc Med 2016 Mar 1;109(3):98-105. Epub 2016 Mar 1.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0141076816631154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794967PMC
March 2016

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.

N Engl J Med 2015 Nov 25;373(19):1814-23. Epub 2015 Sep 25.

From the Dana-Farber Cancer Institute, Boston (T.K.C., P.W.K.); Institut Gustave Roussy, Villejuif, France (B.E.); Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust, London (T.P.); Icon Cancer Care, South Brisbane, QLD, Australia (P.N.M.); Cleveland Clinic, Cleveland (B.I.R.); Aarhus University Hospital, Aarhus, Denmark (F.D.); Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (H.H.); Texas Oncology-Charles A. Sammons Cancer Center, Baylor University, Dallas (T.E.H.); University of Ulsan College of Medicine (J.-L.L.) and Seoul National University Hospital (B.K.) - both in Seoul, South Korea; Helsinki University Central Hospital Cancer Center, Helsinki (K.P.); Washington University in St. Louis, St. Louis (B.J.R.); Sunnybrook Odette Cancer Centre, Toronto (G.A.B.), and Tom Baker Cancer Centre, Calgary, AB (D.Y.C.H.) - both in Canada; National Institute of Oncology, Budapest, Hungary (L.G.); Hospital de la Santa Creu i Sant Pau, Barcelona (P.M.); Medical University of Vienna, Vienna (M.S.); Exelixis, South San Francisco, CA (A.B-H., C.H., C.S., G.M.S.); University of Texas M.D. Anderson Cancer Center, Houston (N.M.T.); and the Memorial Sloan Kettering Cancer Center, New York (R.J.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024539PMC
November 2015

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial.

Oncologist 2015 Oct 25;20(10):1140-8. Epub 2015 Aug 25.

Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591942PMC
October 2015

High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report.

Integr Cancer Ther 2015 Sep 14;14(5):419-27. Epub 2015 Apr 14.

Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1534735415580676DOI Listing
September 2015

Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.

Int J Radiat Oncol Biol Phys 2015 Aug 4;92(5):1016-1026. Epub 2015 Apr 4.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.03.037DOI Listing
August 2015

Management of Clinical Stage I Testicular Cancer: How Should We Define Success?

J Clin Oncol 2015 Jul 1;33(20):2321-2. Epub 2015 Jun 1.

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/20/2321.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.60.8885
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.60.8885DOI Listing
July 2015

Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma.

Clin Genitourin Cancer 2015 Jun 24;13(3):218-24. Epub 2014 Oct 24.

Genitourinary Medical Oncology Department, University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991027PMC
June 2015

Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma.

Carcinogenesis 2015 Feb 18;36(2):249-55. Epub 2014 Dec 18.

Department of Epidemiology, Department of Urology and Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322190PMC
February 2015

Neuroendocrine tumors of the kidney: a single institution experience.

Clin Genitourin Cancer 2014 Dec 11;12(6):422-7. Epub 2014 Jun 11.

Genitourinary Medical Oncology Department, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.06.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253079PMC
December 2014

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.

Invest New Drugs 2014 Dec 22;32(6):1246-57. Epub 2014 Aug 22.

MD, FACP; MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, 1155 Pressler St, Unit 1374, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0151-0DOI Listing
December 2014

Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.

Eur Urol 2014 Nov 7;66(5):874-80. Epub 2014 Feb 7.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.01.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396847PMC
November 2014

Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials.

Int J Radiat Oncol Biol Phys 2014 Nov 13;90(4):870-6. Epub 2014 Sep 13.

Department of Radiation Oncology, University of Texas MD Anderson Cancer, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.07.037DOI Listing
November 2014

Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experience.

Clin Genitourin Cancer 2014 Oct 18;12(5):348-53. Epub 2014 Jan 18.

Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160412PMC
October 2014

The scientific method: pillar and pitfall of cancer research.

Cancer Med 2014 Aug 8;3(4):1035-7. Epub 2014 Apr 8.

Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, P.O. Box 301439, 1155 Pressler Street, Houston, 77230-1439, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303171PMC
August 2014

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

J Urol 2014 Jul 8;192(1):36-42. Epub 2014 Feb 8.

Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.01.086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502598PMC
July 2014

Clinical outcomes for patients with metastatic renal cell carcinoma treated with alternative sunitinib schedules.

J Urol 2014 Mar 7;191(3):611-8. Epub 2013 Sep 7.

Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.08.090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015627PMC
March 2014

Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.

Mol Cancer Ther 2014 Jan 29;13(1):221-9. Epub 2013 Oct 29.

Corresponding Author: Kenneth Y. Tsai, Departments of Dermatology and Immunology, University of Texas MD Anderson Cancer Center, 7455 Fannin, Unit 907, Houston, TX 77054.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366425PMC
January 2014

Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission.

Clin Genitourin Cancer 2013 Sep 9;11(3):370-3. Epub 2013 May 9.

Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.04.005DOI Listing
September 2013

Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.

BJU Int 2013 May 19;111(6):997-1005. Epub 2013 Mar 19.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11608.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637414PMC
May 2013

Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

J Natl Cancer Inst 2013 Mar 2;105(6):424-32. Epub 2013 Feb 2.

Department of Epidemiology, Unit 1340, University of Texas MD Anderson Cancer Center, 1155 Pressler Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djt005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601952PMC
March 2013